Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Timothy Kennedy

Surgical Oncology New Brunswick, NJ Medical Doctor

NPI 1235394255 CMS profile 101594

195 Little Albany St, Suite 560, New Brunswick, NJ 08901

Open in the dashboard

General payments

$4,151

38 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$5,673,502 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Timothy Kennedy of New Brunswick, NJ is reported in the CMS Open Payments database as having received $4,151 across 38 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $5,673,502 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 69th percentile of Surgical Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $872 8
2024 General $1,493 6
2023 General $425 4
2022 General $871 4
2021 General $129 2
2020 General $15 1
2019 General $347 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Timothy Kennedy
  • Surgical Oncology median
  • Middle half of Surgical Oncology
  • National median

In program year 2025, general payments to Timothy Kennedy were reported at $872. Among 1,137 Surgical Oncology profiles paid that year, the median was $288 and the middle half received between $118 and $1,346.

Show as a table
Year Timothy Kennedy Surgical Oncology median Middle half National median
2019 $347 $236 $86–$1,064 $163
2020 $15 $130 $47–$648 $114
2021 $129 $160 $53–$943 $132
2022 $871 $199 $76–$782 $149
2023 $425 $246 $95–$854 $160
2024 $1,493 $271 $106–$1,123 $164
2025 $872 $288 $118–$1,346 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $1,764 11 payments
  2. Stryker Corporation $718 2 payments
  3. Dilon Technologies, Inc. $395 3 payments
  4. Ethicon US, LLC $282 14 payments
  5. Medtronic, Inc. $199 2 payments
  6. Applied Medical Resources Corporation $175 1 payment
  7. Integra LifeSciences Corporation $174 1 payment
  8. Intera Oncology, Inc $138 1 payment
  9. Hologic, LLC $130 1 payment
  10. Histosonics, Inc. $108 1 payment
  11. Other $68 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,153 33 payments
  2. Education $1,106 2 payments
  3. Travel and Lodging $718 2 payments
  4. Consulting Fee $175 1 payment
Products named General payments · program years 2019–2025
  1. DAVINCI XI $1,000 1 payment
  2. Da Vinci Surgical System $764 10 payments
  3. SPY-PHI SYSTEM $718 2 payments
  4. HEMOBLAST BELLOWS $395 3 payments
  5. Integra Recon-Skin And Wound $174 1 payment
  6. Integra Recon-Skin And Wound $174 1 payment
  7. Integra Recon-Skin And Wound $174 1 payment
  8. INTEGRA DERMAL REGENERATION TEMPLATE $174 1 payment
  9. PRIMATRIX $174 1 payment
  10. Signia $159 1 payment
  11. Other $996 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$69,779

Medicare's payments for the services billed

Medicare patients

96

Average age 73

Services billed

261

37 women, 59 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 55%
Diabetes 51%
Cancer 46%
Ischemic heart disease 38%
Depression 35%
Chronic kidney disease 32%
Atrial fibrillation 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

38 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgical Oncology in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record